Pharmaceutical giant Eli Lilly is cutting the cost of insulin products.
- The company says it will cap out-of-pocket costs at $35 a month.
- The cost of insulin has been a major focus for U.S. lawmakers and the White House - President Biden went after "Big Pharma" during last month's State of the Union address.